Drug Type Small molecule drug |
Synonyms SF38 |
Target |
Mechanism DPP-1 inhibitors(Cathepsin C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H17ClN6OS |
InChIKeyCVEIEBFUSJRUSP-UHFFFAOYSA-N |
CAS Registry2825567-97-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | CN | 01 Jun 2022 |